arrow
C

Camille Lobry

Université Paris-Cité
H指数:27
被引数:5,461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncogenic modulation of MAPK signaling in leukemia via SPNS2-driven sphingolipid metabolism and membrane nanodomains remodeling

通过SPNS2驱动的鞘脂代谢和膜纳米域重塑对白血病中MAPK信号通路的致癌性调控

2026-10-280
OAAI
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia

剪接相关网络PAK1-CLK1/4-SRRM1是人类和小鼠急性髓系白血病克服化疗耐药的易感靶点

2026-07-080
PRE
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms

JAK2 抑制介导了骨髓增殖性肿瘤中 RAS 通路突变的克隆选择。

2025-07-080
OAAI
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/ HOXB7 axis in patients with myelofibrosis
2024-12-060
OAAI
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism
2024-10-290
PRE
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program
2024-06-190
OAAI
Targeting a lineage-specific PI3Kγ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule

使用异双功能降解剂分子靶向急性髓性白血病中的谱系特异性PI3Kγ-Akt信号模块

2024-05-302
PRE
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia
LEUKEMIA
IF13.4
2022-12-306
OA
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
LEUKEMIA
IF13.4
2022-04-2637
OA
Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia
2022-02-1112
OAAI
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
2021-01-014
OAAI
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
2020-12-0115
OAAI
Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia
2019-12-0237
OAAI